CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis.
Front Immunol
; 14: 1078958, 2023.
Article
en En
| MEDLINE
| ID: mdl-37025992
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Mastocitosis
/
Mastocitosis Sistémica
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Front Immunol
Año:
2023
Tipo del documento:
Article